
No Stock Yet
No Data
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Gainers Cooper-Standard Holdings Inc. (NYSE:CPS) jumped 69.6% to close at $8.53 on Friday following better-than-expected Q2 results.Intelligent Living Application Group Inc. (NASDAQ:ILAG) surged 64.4%
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Aileron Therapeutics (NASDAQ:ALRN) shares rose 27.9% to $0.22 during Friday's after-market session. This security traded at a volume of 6.5 million shares come close, making up 1454.7% of its
Nasdaq Falls Over 100 Points, Marker Therapeutics Shares Spike Higher
U.S. stocks traded mostly lower toward the end of trading, following the release of jobs data The Dow traded down 0.01% to 32,724.99 while the NASDAQ fell 0.92% to 12,604.01. The S&P also fell, dr
12 Health Care Stocks Moving In Friday's Intraday Session
 Gainers Marker Therapeutics (NASDAQ:MRKR) shares increased by 54.3% to $0.51 during Friday's regular session. The current volume of 63.7 million shares is 16959.7% of Marker Therapeutics's average
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session
Gainers Assure Holdings Corp. (NASDAQ:IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.Cooper-Standard Holdings Inc. (NYSE:CPS) rose 70.4% to $8.57 following better-than-expe
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Signs Off Marker Therapeutics Cell Therapy Study In Lymphoma Setting The FDA cleared Marker Therap
12 Health Care Stocks Moving In Friday's Pre-Market Session
 Gainers Marker Therapeutics (NASDAQ:MRKR) stock moved upwards by 121.9% to $0.73 during Friday's pre-market session. The market value of their outstanding shares is at $61.2 million.Athenex (NASDAQ
India Based Pharma Companies In Race To Buy Athenex, Shares Surge
Athenex Inc (NASDAQ:ATNX) shares climbed during the after-hours session as India's Intas Pharmaceuticals and Dr Reddy's Laboratories Ltd (NYSE:RDY) are reportedly in talks to acquire Athenex.According
Athenex shares are trading higher following reports from Thursday evening suggesting Dr Reddy's and Intas Pharmaceuticals are competing with PE firms to acquire the company.
Athenex shares are trading higher following reports from Thursday evening suggesting Dr Reddy's and Intas Pharmaceuticals are competing with PE firms to acquire the company.
Athenex surges 70% as Dr Reddy's and Intas race to seek buyout deal
The shares of Athenex Inc. (NASDAQ:ATNX) climbed ~70% on rising volumes in the post-market Thursday in reaction to reports that India's Dr Reddy's Laboratories (RDY) and Intas Pharmaceuticals are in t
Loading...
No Stock Yet